Of note, ever since the observations that upregulation of YAP exhibits oncogenic properties and its nuclear accumulation predicts poor prognosis of GC [29,30] , great progress has been made in the last decade in understanding the pathological roles of YAP activation in GC development. The gene discussed is YAP1; the disease is gastric cancer.